¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"absorbed dose conversion factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
minimal erythema dose
ÃÖ¼ÒÈ«¹Ý¼±·®
minimal infecting dose
ÃÖ¼Ò°¨¿°¿ë·®
minimal lethal dose
1. ÃÖ¼ÒÄ¡»ç·® 2. ÃÖ¼ÒÄ¡»ç¼±·®
minimum dose
1. ÃÖ¼Ò¿ë·® 2. ÃÖ¼Ò¼±·®
maximum allowable dose
ÃÖ´ëÇã¿ë·®
maximum dose
1. ÃÖ´ë¿ë·® 2. ÃÖ´ë¼±·®
maximum tolerance dose
1. ÃÖ´ë³»¾à¿ë·®, ÃÖ´ë³»¾à·® 2. ÃÖ´ë°ßµõ¼±·®
mean effective dose
Æò±ÕÀ¯È¿¼±·®
mean lethal dose
1. Æò±ÕÄ¡»ç¿ë·® 2. Æò±ÕÄ¡»ç¼±·®
median effective dose
1. Áß°£À¯È¿¿ë·® 2. Áß°£À¯È¿¼±·®
median lethal dose
1. Áß°£Ä¡»ç¿ë·® 2. Áß°£Ä¡»ç¼±·®
metered-dose inhaler
°è·®ÈíÀÔ±â
nominal standard dose
¸í¸ñÇ¥Áؼ±·®
optimum dose
1. ÀûÁ¤¿ë·® 2. ÀûÁ¤¼±·®
organ tolerance dose
±â°ü°ßµõ¼±·®
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
lethal dose
Ä¡»ç¿ë·®, Ä¡»ç·®, Ä¡»ç¼±·®
loading dose
ºÎÇϿ뷮, ºÎÇÏ·®
maintenance dose
À¯Áö¿ë·®
maximum dose
ÃÖ´ë¿ë·®, ÃÖ´ë¼±·®
maximum allowable dose
ÃÖ´ëÇã¿ë·®
maximum tolerance dose
ÃÖ´ë³»¾à¿ë·®, ÃÖ´ë³»¾à·®, ÃÖ´ë°ßµõ¼±·®
mean effective dose
Æò±ÕÀ¯È¿¼±·®
mean lethal dose
Æò±ÕÄ¡»ç·®, Æò±ÕÄ¡»ç¼±·®
median effective dose
Áß°£À¯È¿·®, Áß°£À¯È¿¼±·®
median lethal dose
Áß°£Ä¡»ç·®, Áß°£Ä¡»ç¼±·®
minimal effective dose
ÃÖ¼ÒÀ¯È¿·®
minimal erytherma dose
ÃÖ¼ÒÈ«¹Ý¼±·®
minimal lethal dose
ÃÖ¼ÒÄ¡»ç·®, ÃÖ¼ÒÄ¡»ç¼±·®
nominal standard dose
¸í¸ñÇ¥Áؼ±·®
optimum dose
ÀûÁ¤¿ë·®, ÀûÁ¤¼±·®
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
B cell differentiation factor (BCDF)
B¼¼Æ÷ ºÐÈÀ¯¹ßÀÎÀÚ
B cell growth factor
B ¼¼Æ÷¼ºÀåÀÎÀÚ
B cell growth factor (BCGF)
B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
B cell stimulating factor (BSF)
B¼¼Æ÷ ÀÚ±ØÀÎÀÚ
Castles extrinsic factor
Ĺ½½¿ÜÀÎÀÚ.
Castles intrinsic factor
Ĺ½½³»ÀÎÀÚ.
Christmas factor
Å©¸®½º¸¶½º ÀÎÀÚ(ì×í)
Christmas factor.
Å©¸®½º¸¶½ºÀÎÀÚ
D factor
DÀÎÀÚ
Decay accelerating factor
ºØ±«°¡¼Ó¿ä¼Ò(¿äÀÎ)
EDCF (endothlium-derived contracting factor)
³»ÇǼ¼Æ÷¼º(Ò®ù«á¬øààõ) ¼öÃàÀÎÀÚ(â¥õêì×í)
EDRF (endothlium-derived relaxing factor)
³»ÇǼ¼Æ÷¼º(Ò®ù«á¬øààõ) ÀÌ¿ÏÀÎÀÚ(ì¬èÐì×í)
EDRF=£¾endothelium derived relaxing factor
³»ÇǼ¼Æ÷¼ºÀÌ¿ÏÀÎÀÚ.
F factor
FÀÎÀÚ
Factor IX
IX ÀÀ°íÀÎÀÚ(ëêͳì×í)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
arbitrary dose
ÀÓÀǿ뷮(ìòëòéÄåÖ).
average dose
Æò±Õ¿ë·®, Æò±ÕÁ¶»ç·®.
basal dose
±âº»¼±·®
biological isoeffect dose
»ý¹°ÇÐÀûµîÈ¿°ú¼±·®
biologically effective dose
»ý¹°ÇÐÀûÀ¯È¿¼±·®
boost dose
Ãß°¡¼±·®
booster dose
Ãß°¡Á¢Á¾·®, Ãß°¡·®(õÚÊ¥åÖ), ºÎ¿ì½ºÅͿ뷮.
carcinoma dose
Á¦¾Ï·®.
central axis depth dose
Áß½ÉÃà½ÉºÎ¼±·®
child dose
¼Ò¾Æ¾à¿ë·®(¡å·éÄåÖ).
collective effective dose
Áý´ÜÀ¯È¿¼±·®
collective equivalent dose
Áý´Ü´ç·®¼±·®
committed dose equivalent
¿¹Å¹¼±·®´ç·®
committed effective dose
¿¹Å¹À¯È¿¼±·®
committed effective dose equivalent
¿¹Å¹À¯È¿¼±·®´ç·®
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½